RVD regimen: Difference between revisions

	WikiDoc Resources for RVD regimen
Articles
Most recent articles on RVD regimen Most cited articles on RVD regimen Review articles on RVD regimen Articles on RVD regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on RVD regimen Images of RVD regimen Photos of RVD regimen Podcasts & MP3s on RVD regimen Videos on RVD regimen
Evidence Based Medicine
Cochrane Collaboration on RVD regimen Bandolier on RVD regimen TRIP on RVD regimen
Clinical Trials
Ongoing Trials on RVD regimen at Clinical Trials.gov Trial results on RVD regimen Clinical Trials on RVD regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on RVD regimen NICE Guidance on RVD regimen NHS PRODIGY Guidance FDA on RVD regimen CDC on RVD regimen
Books
Books on RVD regimen
News
RVD regimen in the news Be alerted to news on RVD regimen News trends on RVD regimen
Commentary
Blogs on RVD regimen
Definitions
Definitions of RVD regimen
Patient Resources / Community
Patient resources on RVD regimen Discussion groups on RVD regimen Patient Handouts on RVD regimen Directions to Hospitals Treating RVD regimen Risk calculators and risk factors for RVD regimen
Healthcare Provider Resources
Symptoms of RVD regimen Causes & Risk Factors for RVD regimen Diagnostic studies for RVD regimen Treatment of RVD regimen
Continuing Medical Education (CME)
CME Programs on RVD regimen
International
RVD regimen en Espanol RVD regimen en Francais
Business
RVD regimen in the Marketplace Patents on RVD regimen
Experimental / Informatics
List of terms related to RVD regimen

VisualWikitext

Latest revision as of 18:40, 30 March 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:Bortezomib/Dexamethasone/Lenalidomide Regimen; RVD; Velcade/Revlimid/Dexamethasone; VRD; VDR

Overview

RVD regimen refers to a treatment regimen consisting of a combination of revlimid (lenalidomide), velcade (bortezomib) and dexamethasone used in the treatment of multiple myeloma^[1]^[2]

Regimen

RRevlimid (lenalidomide)

VVelcade (Bortezomib)

DDexamethasone

Indications

Multiple myeloma^[1]

References

↑ ^1.0 ^1.1 Nooka AK, Kaufman JL, Muppidi S, Langston A, Heffner LT, Gleason C; et al. (2014). "Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients". Leukemia. 28 (3): 690–3. doi:10.1038/leu.2013.335. PMID 24220275.
↑ "NCI Thesaurus".

[pmid24220275-1] 1.0 ^1.1 Nooka AK, Kaufman JL, Muppidi S, Langston A, Heffner LT, Gleason C; et al. (2014). "Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients". Leukemia. 28 (3): 690–3. doi:10.1038/leu.2013.335. PMID 24220275.

[2] "NCI Thesaurus".

[1]

[2]

@@ Line 6: / Line 6: @@
 ==Overview==
-{{PAGENAME}} refers to a treatment regimen consisting of a combination of [[bortezomib|velcade (bortezomib)]], [[dexamethasone]] and [[lenalidomide|revlimid (lenalidomide)]]used in the treatment of [[multiple myeloma]]<ref name="pmid24220275">{{cite journal| author=Nooka AK, Kaufman JL, Muppidi S, Langston A, Heffner LT, Gleason C et al.| title=Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients. | journal=Leukemia | year= 2014 | volume= 28 | issue= 3 | pages= 690-3 | pmid=24220275 | doi=10.1038/leu.2013.335 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24220275 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C113827&ns=NCI_Thesaurus}}</ref>
+{{PAGENAME}} refers to a treatment regimen consisting of a combination of [[lenalidomide|revlimid (lenalidomide)]], [[bortezomib|velcade (bortezomib)]] and [[dexamethasone]] used in the treatment of [[multiple myeloma]]<ref name="pmid24220275">{{cite journal| author=Nooka AK, Kaufman JL, Muppidi S, Langston A, Heffner LT, Gleason C et al.| title=Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients. | journal=Leukemia | year= 2014 | volume= 28 | issue= 3 | pages= 690-3 | pmid=24220275 | doi=10.1038/leu.2013.335 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24220275 }} </ref><ref>{{Cite web | title = NCI Thesaurus | accessdate =  | url = http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C113827&ns=NCI_Thesaurus}}</ref>
 ==Regimen==
 {{chemo|R|Revlimid (lenalidomide)}}
@@ Line 17: / Line 16: @@
 ==Indications==
+* [[Multiple myeloma]]<ref name="pmid24220275">{{cite journal| author=Nooka AK, Kaufman JL, Muppidi S, Langston A, Heffner LT, Gleason C et al.| title=Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients. | journal=Leukemia | year= 2014 | volume= 28 | issue= 3 | pages= 690-3 | pmid=24220275 | doi=10.1038/leu.2013.335 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24220275 }} </ref>
-*[[Multiple myeloma]]<ref name="pmid24220275">{{cite journal| author=Nooka AK, Kaufman JL, Muppidi S, Langston A, Heffner LT, Gleason C et al.| title=Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients. | journal=Leukemia | year= 2014 | volume= 28 | issue= 3 | pages= 690-3 | pmid=24220275 | doi=10.1038/leu.2013.335 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24220275 }} </ref>
 ==References==
 {{Reflist|2}}
 [[Category:Chemotherapy regimens]]